Skip to Content

News and events

Covid-19 vaccination

The advent of an effective vaccine for Covid-19, is wonderful news and represents a truly astonishing scientific achievement.  Over the past few months, the UK Government has implemented a…


Do you shop with Amazon?  If so, did you also know that Amazon have created a resource that will allow PAPAA to receive a donation at no cost to you?


Psoriasis in Practice course fully updated

The new version 7 of PAPAA's popular Psoriasis in Practice digital resource online training programme is now available until 29 April 2022.  The programme is aimed at helping frontline healthcare…

Co-codamol 30/500 Effervescent Tablets recalled

People who use Co-codamol 30/500 Effervescent Tablets, widely used for pain relief, are today being asked to check the batch number on the labels of packs to ensure they are not one of 4,464 packs…

Care, Cause, Cure: the PAPAA vision

See our new video that is part of our strategy to raise awareness of psoriasis and psoriatic arthritis and includes our mission to look and delve deeper into the causes of psoriatic disease by…

Guselkumab recommended by NICE

Guselkumab (Tremfya), taken with or without methotrexate, has been recommended by the National Institute for Health and Care Excellence (NICE) and is available on the NHS.

Latest journal now available

Skin 'n' Bones Connection issue 53 is now available. The journal is aimed at people affected by psoriasis and psoriatic arthritis.